RET-mutated recurrent leiomyosarcoma treated with cabozantinib: a case report

We present the case of a 68-year-old man with a recurrence of a high-grade leiomyosarcoma with metastatic disease. Despite initial treatment with liposomal doxorubicin, disease progression was observed after three cycles. A molecular study revealed an activating mutation of the RET gene, and treatme...

Full description

Bibliographic Details
Main Authors: Carlos E. Salazar-Mejía, Javier A. Martínez-Moyano, Hugo E. Solis-Lara, Eduardo J. Cantú-Casas, Frida Valle-Domínguez, Valeria S. Narvaez-Gonzalez, Oscar Vidal-Gutiérrez, David Hernández-Barajas
Format: Article
Language:English
Published: Permanyer 2023-07-01
Series:Medicina Universitaria
Subjects:
Online Access:https://www.medicinauniversitaria.org/frame_eng.php?id=223